M. Toruner Et Al. , "Concomitant azathioprine treatment effects vedolizumab treatment persistence in Crohn's Disease but not in Ulcerative Colitis," JOURNAL OF CROHNS & COLITIS , vol.17, pp.531-532, 2023
Toruner, M. Et Al. 2023. Concomitant azathioprine treatment effects vedolizumab treatment persistence in Crohn's Disease but not in Ulcerative Colitis. JOURNAL OF CROHNS & COLITIS , vol.17 , 531-532.
Toruner, M., Guvenir, T., Er, R. E., & SOYKAN, A. İ., (2023). Concomitant azathioprine treatment effects vedolizumab treatment persistence in Crohn's Disease but not in Ulcerative Colitis. JOURNAL OF CROHNS & COLITIS , vol.17, 531-532.
Toruner, M. Et Al. "Concomitant azathioprine treatment effects vedolizumab treatment persistence in Crohn's Disease but not in Ulcerative Colitis," JOURNAL OF CROHNS & COLITIS , vol.17, 531-532, 2023
Toruner, M. Et Al. "Concomitant azathioprine treatment effects vedolizumab treatment persistence in Crohn's Disease but not in Ulcerative Colitis." JOURNAL OF CROHNS & COLITIS , vol.17, pp.531-532, 2023
Toruner, M. Et Al. (2023) . "Concomitant azathioprine treatment effects vedolizumab treatment persistence in Crohn's Disease but not in Ulcerative Colitis." JOURNAL OF CROHNS & COLITIS , vol.17, pp.531-532.
@article{article, author={M. Toruner Et Al. }, title={Concomitant azathioprine treatment effects vedolizumab treatment persistence in Crohn's Disease but not in Ulcerative Colitis}, journal={JOURNAL OF CROHNS & COLITIS}, year=2023, pages={531-532} }